As of Oct 02
| +0.12 / +4.86%|
The 2 analysts offering 12-month price forecasts for Novogen Ltd have a median target of 6.47, with a high estimate of 7.93 and a low estimate of 5.00. The median estimate represents a +149.70% increase from the last price of 2.59.
The current consensus among 2 polled investment analysts is to Buy stock in Novogen Ltd. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.